Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance.

García-Marco JA, Jiménez JL, Recasens V, Zarzoso MF, González-Barca E, De Marcos NS, Ramírez MJ, Parraga FJP, Yañez L, De La Serna Torroba J, Malo MDG, Ariznavarreta GD, Persona EP, Guinaldo MAR, De Paz Arias R, Llanos EB, Jarque I, Valle MDCF, Tatay AC, De Oteyza JP, Martin EMD, Fernández IP, Martinez RM, Costa MAA, Champ D, Suarez JG, Díaz MG, Ferrer S, Carbonell F, García-Vela JA; GELLC Study Group.

Haematologica. 2019 Nov;104(11):2249-2257. doi: 10.3324/haematol.2018.204891. Epub 2019 Mar 19.

2.

Response to "Incidence and self-management of hand-foot syndrome in patients with colorectal cancer".

Llanos EB.

Clin J Oncol Nurs. 2014 Apr;18(2):143. No abstract available.

PMID:
24809073
3.

Steps must be double checked.

Llanos EB.

Clin J Oncol Nurs. 2013 Apr;17(2):113. No abstract available.

PMID:
23687691
4.

A multisite Nurses Week celebration.

Llanos EB.

Nurs Manage. 2013 May;44(5):37-9. doi: 10.1097/01.NUMA.0000429002.62516.bd. No abstract available.

PMID:
23608940
5.

Understanding the difficulty.

Llanos EB.

Clin J Oncol Nurs. 2013 Apr;17(2):213-4. doi: 10.1188/13.CJON.213-214. No abstract available.

PMID:
23538261
6.

Accessing implanted ports remains controversial.

Llanos EB.

Clin J Oncol Nurs. 2011 Oct;15(5):456. doi: 10.1188/11.CJON.456. No abstract available.

PMID:
21951731

Supplemental Content

Loading ...
Support Center